Clinical Trials Browser

Cholangiocarcinoma × Erlotinib Hydrochloride × Gastrointestinal × Clear all

NCT00832637 2018-06-29

Gem-ox

Phase 2 Terminated

33 enrolled 9 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT00955149 2014-01-10

Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)

Phase 1 Completed

Gastrointestinal

Cholangitis, Sclerosing, Cholangiocarcinoma

NCT00350753 2009-07-15

Avastin and Tarceva for Upper Gastrointestinal Cancers

Phase 2 Completed

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma